4Filing Date: Dec 30, 2025

Gilead (GILD) 4: O'Day Daniel Patrick sold 10,000 shares of Common Stock at… (Dec 30, 2025)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001638643-25-000017
Total Value$1.25M
Trades1
Insiders1

Transaction Details

O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Sell · Dispose
Common Stock
Shares-10.00K
Price$124.83
Total Value$1.25M
Shares Owned After566.70K
Transaction DateDec 29, 2025
10b5-1
Footnotes ▸

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. | Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Post-Transaction Holdings

O'Day Daniel Patrick · Chairman & CEO, Director
SecuritySharesChange
Common Stock566.70K-10.00K (-1.73%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2025-12-29 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: GILEAD SCIENCES, INC. (GILD) CIK: 0000882095 --- Reporting Owner --- Name: O'Day Daniel Patrick CIK: 0001638643 Role: Director, Officer (Chairman & CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2025-12-29 | Code: S (Open market sale) Shares: -10,000 | Price: $124.83 Total Value: $1,248,272.00 Shares Owned After: 566,698 | Ownership: D (Direct) Footnotes: [F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. [F2] Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. --- Footnotes (Complete Index) --- F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F2: Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. --- Signature --- /s/ /s/ Edward S. Son by Power of Attorney for Daniel P. O'Day (2025-12-30)

keid analysis is for reference only and does not constitute investment advice.